AI Science Tracker
EN

Interpretable machine learning models for the prediction of all-cause mortality and time to death in hemodialysis patients.

Affiliation not stated in the reviewed material · 26 Sep 2024 · medicine

Discovery

Interpretable machine learning models for the prediction of all-cause mortality and time to death in hemodialysis patients.

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary full-text record describes a 359-patient retrospective hemodialysis cohort and evaluated ML mortality/time-to-death predictions; this supports a specific clinical prediction study, not clinical benefit.

Technology: Random forest, support-vector machine and logistic-regression models predict all-cause mortality; random-forest regression estimates time to death, with SHAP factor interpretation.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random forest, support-vector machine and logistic-regression models predict all-cause mortality; random-forest regression estimates time to death, with SHAP factor interpretation.
Test and result
In 359 hemodialysis patients, the optimized full-variable random forest had mortality AUROC 0.86±0.07 (sensitivity 0.86, specificity 0.75); a 22-variable model had AUROC 0.80±0.06.
Limitation / still unknown
Retrospective single-cohort prediction does not establish improved survival or generalization to other dialysis populations.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11879476/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.